MLECW logo

Moolec Science S.A.

MLECW
Healthcare|Biotechnology|KY
$0.01
+0.00 (+0.01%)
DCF Value
$549.06
Cash / Share
$1.40

About

Moolec Science S.A. operates as a science-driven ingredient company focused on generating animal proteins inside plants through a groundbreaking method called Molecular Farming. This innovative approach is considered a disruptive force in the alternative protein sector. The firm's existing and future products strategically utilize the strong agricultural performance of key crops, such as soybeans and peas. Established in 2008, Moolec Science S.A. is headquartered in Luxembourg and conducts business across the United States, Europe, and South America.

Stock Price

-52.7%(1Y)
1M
-44.4%
3M
-49.3%
6M
-65.3%
YTD
+20.7%
1Y
-50.0%
3Y
-73.7%
5Y
-96.7%

Pipeline Summary

0 total trials
0
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4

Key Facts

Market Cap$76.2K
Employees103
CEOAlejandro Antalich
IPO DateJan 3, 2023
Beta0.09
52-Week Range$0.0018 – $0.16
Avg Volume104,369
ExchangeNASDAQ

Ownership

Float71.2%
Shares Outstanding10.9M

Peers

AIMAIM ImmunoTech Inc.
$6.2M
BCLIBrainstorm Cell Therapeutics Inc.
$9.9M
CEROCERo Therapeutics Holdings, Inc.
$214.9K
CYCNCyclerion Therapeutics, Inc.
$15.7M
IBOImpact BioMedical Inc.
$35.5M
NRSNNeuroSense Therapeutics Ltd.
$3.2M
TCRTAlaunos Therapeutics, Inc.
$6.0M
VIVSVivoSim Labs, Inc.
$2.3M
Data last updated: Nov 9, 2026, 04:22 AM